Tectonic Therapeutic (TECX) Non-Current Deffered Revenue (2017 - 2022)

Tectonic Therapeutic (TECX) has 6 years of Non-Current Deffered Revenue data on file, last reported at $10000.0 in Q3 2022.

• On a quarterly basis, Non-Current Deffered Revenue fell 88.89% year-over-year to $10000.0 in Q3 2022; TTM through Sep 2022 was $10000.0, a 88.89% decrease from a year earlier, with the FY2021 full-year figure at $30000.0, down 89.13% from the prior year.
• Non-Current Deffered Revenue for Q3 2022 stood at $10000.0, down from $12000.0 in the prior quarter.
• Over the last five years, Non-Current Deffered Revenue for TECX reached as high as $781000.0 in Q2 2018 and fell as low as $10000.0 in Q3 2022.
• Historically, Non-Current Deffered Revenue has averaged $340722.2 across 5 years, with a median of $303500.0 in 2020.
• Across the five-year window, Non-Current Deffered Revenue soared 446.83% in 2018 and plunged 92.0% in 2022, its largest moves.
• Year by year, Non-Current Deffered Revenue stood at $689000.0 in 2018, then tumbled by 68.94% to $214000.0 in 2019, then climbed by 28.97% to $276000.0 in 2020, then slumped by 89.13% to $30000.0 in 2021, then slumped by 66.67% to $10000.0 in 2022.
• Per Business Quant data, the three most recent Non-Current Deffered Revenue figures were $10000.0 in Q3 2022, $12000.0 in Q2 2022, and $30000.0 in Q1 2022.